LUMO goes private @$4.25/sh+CVR—an 8% premium to yesterday’s close: https://www.globenewswire.com/news-release/2024/10/23/2967721/15114/en/Lumos-Pharma-Enters-into-Definitive-Merger-Agreement-with-Double-Point-Ventures-to-Go-Private-via-a-Tender-Offer-of-4-25-Cash-per-Share-Plus-Contingent-Value-Rights-CVR.html The buyer is Double Point Ventures LLC. The nominal deal value is $38M.